CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1696993.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
B lymphocytes which express the CD5 antigen on their cell surface have the ability to produce autoantibodies in vitro. We describe 2 patients, one with systemic lupus erythematosus and another with rheumatoid arthritis, whose percentages of peripheral blood CD5+ B lymphocytes were dramatically increased to 68 and 100%, respectively. A reduction of this subpopulation of B cells was associated with clinical improvement after therapy. This association suggests a relationship between CD5+ B cells and autoimmune disease activity.
Medical subject headings
- Antigens, Differentiation
- Arthritis, Rheumatoid
- B-Lymphocytes
- Lupus Erythematosus, Systemic